Athenex

-$0.0065 (-1.31%) Today
+$0.0245 (+4.98%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Athenex and other ETFs, options, and stocks.

About ATNX

Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of novel therapies for the treatment of cancer. It operates through the following segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform.

CEO
Yiu Nam Lau
Employees
666
Headquarters
Buffalo, New York
Founded
2003

ATNX Key Statistics

Market cap
54.96M
Price-Earnings ratio
—
Dividend yield
—
Average volume
785.07K
High today
$0.50
Low today
$0.475
Open price
$0.4953
Volume
739.83K
52 Week high
$5.27
52 Week low
$0.4329

ATNX Earnings

-$0.53
-$0.35
-$0.18
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure